- Retinoic Acid Reduces Stem Cell–Like Features in Pancreatic Cancer Cells
Marta Herreros-Villanueva et al, 2015, Pancreas CrossRef - Phosphorylation of the C-Raf N Region Promotes Raf Dimerization
Maho Takahashi et al, 2017, Molecular and Cellular Biology CrossRef - Pancreatic cancer stem cells and inflammation: milestones achieved and challenges ahead
Loganayaki Periyasamy et al, 2024, Cancer Stem Cells and Signaling Pathways CrossRef - ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism
Hanxun Yue et al, 2022, Frontiers in Oncology CrossRef - Src Inhibition Can Synergize with Gemcitabine and Reverse Resistance in Triple Negative Breast Cancer Cells via the AKT/c-Jun Pathway
Zhen-Hua Wu et al, 2016, PLOS ONE CrossRef - Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
Kyu Sic You et al, 2021, Pharmaceuticals CrossRef - Anti-Cancer Stem-like Cell Compounds in Clinical Development – An Overview and Critical Appraisal
Fabrizio Marcucci et al, 2016, Frontiers in Oncology CrossRef - Comparative analysis of NRF2-responsive gene expression in AcPC-1 pancreatic cancer cell line
Yong Weon Yi et al, 2015, Genes & Genomics CrossRef - Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer Cells
Hong-Quan Duong et al, 2017, Antioxidants CrossRef - Aldehyde Dehydrogenase Genes as Prospective Actionable Targets in Acute Myeloid Leukemia
Garrett M. Dancik et al, 2023, Genes CrossRef - Magnetic Fluid Hyperthermia as Treatment Option for Pancreatic Cancer Cells and Pancreatic Cancer Organoids
Julian Palzer et al, 2021, International Journal of Nanomedicine CrossRef - Identification of inhibitors synergizing gemcitabine sensitivity in the squamous subtype of pancreatic ductal adenocarcinoma (PDAC)
Jia Lin Er et al, 2018, Apoptosis CrossRef - Combinatorial Strategies to Target Molecular and Signaling Pathways to Disarm Cancer Stem Cells
Giuliana Catara et al, 2021, Frontiers in Oncology CrossRef - Encapsulated Cells Expressing a Chemotherapeutic Activating Enzyme Allow the Targeting of Subtoxic Chemotherapy and Are Safe and Efficacious: Data from Two Clinical Trials in Pancreatic Cancer
J. Löhr et al, 2014, Pharmaceutics CrossRef - Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action
Tobias Bartscht et al, 2015, Molecular Cancer CrossRef - Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer Cells
Kyu Sic You et al, 2021, Cancers CrossRef - Study on tumour cell-derived hybrid exosomes as dasatinib nanocarriers for pancreatic cancer therapy
Xiaofei Zhou et al, 2023, Artificial Cells, Nanomedicine, and Biotechnology CrossRef - Dasatinib can enhance paclitaxel and gemcitabine inhibitory activity in human pancreatic cancer cells
Ling Ma et al, 2019, Cancer Biology & Therapy CrossRef - A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors
Niharika B. Mettu et al, 2019, Cancer Chemotherapy and Pharmacology CrossRef